Should I, as the primary care physician, clear the patient to stop apixaban (Eliquis) three days before a lumbar epidural, and how should I manage the timing based on renal function and thrombotic risk?

Clearance for Stopping Apixaban Before Lumbar Epidural

Yes, you should clear the patient to stop apixaban 2-3 days prior to the lumbar epidural, with the exact timing determined by renal function: 2 days (48 hours) for normal renal function (CrCl ≥50 mL/min) and 3 days (72 hours) for impaired renal function (CrCl <50 mL/min).

Timing of Apixaban Discontinuation

Lumbar epidural procedures are classified as high bleeding risk due to the potential for catastrophic neuraxial bleeding 1. The FDA label explicitly states that apixaban should be discontinued at least 48 hours prior to elective surgery or invasive procedures with moderate or high risk of bleeding 2.

However, the specific timing depends on the patient's renal function:

For Normal Renal Function (CrCl ≥30 mL/min):

• Stop apixaban 2 days (48 hours) before the procedure 1
• This corresponds to approximately 4-5 elimination half-lives (apixaban half-life is ~12 hours), resulting in minimal residual anticoagulation 3
• Real-world data confirms that 48-hour cessation achieves clinically insignificant anticoagulation levels (94% of patients had concentrations ≤30 ng/mL) 4

For Impaired Renal Function (CrCl <50 mL/min):

• Stop apixaban 3 days (72 hours) before the procedure 1
• Apixaban accumulates significantly in renal impairment—patients with moderate renal impairment have roughly twice the exposure compared to those with normal function 5
• Dose-adjusted concentrations are 3.3-fold higher in severe renal impairment (GFR <30 mL/min) 6

Critical Assessment Required

Before clearing the patient, you must evaluate:

1. Renal function: Calculate CrCl or eGFR to determine appropriate cessation interval
2. Thrombotic risk: Assess stroke risk (CHA₂DS₂-VASc score if AF) and VTE risk
3. Current apixaban dose: Standard 5 mg BID vs. reduced 2.5 mg BID dosing
4. Time since last dose: Confirm patient can achieve the required drug-free interval

Bridging Anticoagulation

Bridging is NOT recommended for apixaban cessation before elective procedures 2, 7. The FDA label explicitly states: "Bridging anticoagulation during the 24 to 48 hours after stopping ELIQUIS and prior to the intervention is not generally required" 2.

Resumption After Procedure

• Resume apixaban at least 48-72 hours post-procedure for high bleeding risk procedures like neuraxial interventions 3
• Restart only after adequate hemostasis is established 2
• For patients at very high thrombotic risk, consider low-dose prophylactic anticoagulation during the initial 2-3 days before resuming full-dose apixaban 3

Important Caveats

Renal function is critical: The 3-day recommendation from pain management may be appropriate if the patient has any degree of renal impairment. Apixaban is 27% renally eliminated, and accumulation occurs even with moderate CKD 2, 5. Given that most patients requiring anticoagulation are elderly with some baseline renal dysfunction, the conservative 3-day approach is often safer.

Avoid premature clearance: Do not clear the patient until you've confirmed adequate renal function assessment. The difference between 2 and 3 days of cessation can be clinically significant in patients with CrCl 30-50 mL/min 1.

Document thrombotic risk: While you should clear the cessation, document the patient's stroke/VTE risk and confirm the procedure cannot be safely delayed if thrombotic risk is extremely high (though this rarely applies to elective pain procedures).